BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Breast cancer AND KDM6A, O15550, UTX, 7403, ENSG00000147050, DKFZp686A03225, RP13-886N14_3, MGC141941, bA386N14_2 AND Prognosis
15449 results:

  • 1. Retrospective analysis of estrogen receptor (ER), progesterone receptor (PR), human epidermal growth factor receptor-2 (HER2), Ki67 changes and their clinical significance between primary breast cancer and metastatic tumors.
    Qi G; Zhang X; Gai X; Yan X
    PeerJ; 2024; 12():e17377. PubMed ID: 38766488
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. The prognostic value of preoperative neoindices consisting of lymphocytes, neutrophils and albumin (LANR) in operable breast cancer: a retrospective study.
    Wang Y; Zhuang J; Wang S; Wu Y; Chen L
    PeerJ; 2024; 12():e17382. PubMed ID: 38766483
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. D-arabinose induces cell cycle arrest by promoting autophagy via p38 MAPK signaling pathway in breast cancer.
    Tang Z; Song H; Qin S; Tian Z; Zhang C; Zhou Y; Cai R; Zhu Y
    Sci Rep; 2024 May; 14(1):11219. PubMed ID: 38755221
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. The emerging role and mechanism of HMGA2 in breast cancer.
    Ma Q; Ye S; Liu H; Zhao Y; Zhang W
    J Cancer Res Clin Oncol; 2024 May; 150(5):259. PubMed ID: 38753081
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. CircAGFG1 Promotes Ovarian cancer Progression Through the miR-409-3 p/ZEB1 Axis.
    Luo J; Zhong H; Guo M; Xiao P; Cao R; Zhao M; Jing Y
    Technol Cancer Res Treat; 2024; 23():15330338241252423. PubMed ID: 38752261
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Patterns of distant metastasis and survival outcomes in
    Liu K; Huang AL; Chen XQ; Wu SG
    Front Endocrinol (Lausanne); 2024; 15():1385756. PubMed ID: 38752173
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. circATAD2 mitigates CD8
    Zhang Z; Huo W; Li J
    Cancer Immunol Immunother; 2024 May; 73(7):130. PubMed ID: 38748254
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. RPGRIP1L as a new biomarker for prognosis and tumor immune of breast cancer.
    Yi J; Liu L; Chen Y; Ding T; Fan P; Yu J; Zeng J
    FASEB J; 2024 May; 38(9):e23624. PubMed ID: 38747001
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Correlation of Ki-67 proliferative index with oncotype DX recurrence score in hormone receptor-positive, human epidermal growth factor receptor 2-negative early breast cancer with low-burden axillary nodal disease - a review of 137 cases.
    Saad Abdalla Al-Zawi A; Anichkina KA; Elamass M; Aladili Z
    Pol J Pathol; 2024; 75(1):8-18. PubMed ID: 38741425
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Efficacy and safety of pyrotinib combined with albumin-bound paclitaxel as first-line treatment for HER2-positive metastatic breast cancer in patients previously treated with adjuvant and/or neoadjuvant trastuzumab therapy: The stage 1 results of a single-arm, phase 2 prospective clinical trial.
    Man X; Huang J; Sun S; Zhou D; Zhang B; Fang S; Zheng F; Li C; Wang X; Huang W; Wang L; He Q; Fu H; Zhang Y; Liu C; Dong L; Zhao X; Xu L; Sun X; Fan B; Song L; Zhou Z; Yu J; Li H
    Clin Transl Med; 2024 May; 14(5):e1687. PubMed ID: 38738791
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Transcript and protein signatures derived from shared molecular interactions across cancers are associated with mortality.
    Zhao Y; Li X; Loscalzo J; Smelik M; Sysoev O; Wang Y; Mahmud AKMF; Mansour Aly D; Benson M
    J Transl Med; 2024 May; 22(1):444. PubMed ID: 38734658
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Impact of obesity on sentinel lymph node biopsy outcomes and survival in breast cancer patients: A single-center retrospective study.
    Pang J; Li L; Yin N; Dai M; Zheng S; Chen M; Xue J; Wu J
    Cancer Med; 2024 May; 13(9):e7248. PubMed ID: 38733197
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. E3 ubiquitin ligase BCA2 promotes breast cancer stemness by up-regulation of SOX9 by LPS.
    Zheng M; Liu W; Zhang R; Jiang D; Shi Y; Wu Y; Ge F; Chen C
    Int J Biol Sci; 2024; 20(7):2686-2697. PubMed ID: 38725852
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. A Competing Risk Nomogram for Prediction of prognosis in Patients With Primary Squamous Cell Thyroid Carcinoma.
    Tian Y; He L; Zhang B; Deng L; Wang J
    Technol Cancer Res Treat; 2024; 23():15330338241254059. PubMed ID: 38725285
    [No Abstract]    [Full Text] [Related]  

  • 15. Role of Magnetic Resonance Mammography in the Evaluation of Indeterminate breast Lesions.
    Mishra E; Kaur N; Kaur R; Dalal U; Handa U; Anand GS
    J Assoc Physicians India; 2023 Nov; 71(11):76-84. PubMed ID: 38720501
    [No Abstract]    [Full Text] [Related]  

  • 16. Overexpressing S100A9 ameliorates NK cell dysfunction in estrogen receptor-positive breast cancer.
    Liu Y; Li M; Fang Z; Gao S; Cheng W; Duan Y; Wang X; Feng J; Yu T; Zhang J; Wang T; Hu A; Zhang H; Rong Z; Shakila SS; Shang Y; Kong F; Liu J; Li Y; Ma F
    Cancer Immunol Immunother; 2024 May; 73(7):117. PubMed ID: 38713229
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Time Kinetics and prognosis roles of calcitonin after surgery for medullary thyroid carcinoma.
    Guo F; Fu G; Li F; Hua Y; Wang Z; Zheng X; Zhao J; Gao M
    World J Surg Oncol; 2024 May; 22(1):121. PubMed ID: 38711029
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Effect of young age (below 40 years) on oncologic outcomes in Lebanese patients with breast cancer: a matched cohort study.
    Sbaity E; Tamim H; El-Hajj Fuleihan G; Abbas J; Zahwe M; El Sayed R; Shamseddine A
    BMC Cancer; 2024 May; 24(1):560. PubMed ID: 38704543
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Factors influencing TSH suppression efficacy in postoperative papillary thyroid carcinoma patients: a retrospective cohort study.
    Zhang Q; Zhong ZZ; Wu T; He YQ
    BMC Surg; 2024 May; 24(1):133. PubMed ID: 38702652
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Priming with oncolytic adenovirus followed by anti-PD-1 and paclitaxel treatment leads to improved anti-cancer efficacy in the 3D TNBC model.
    Kuryk L; Mathlouthi S; Wieczorek M; Gad B; Rinner B; Malfanti A; Mastrotto F; Salmaso S; Caliceti P; Garofalo M
    Eur J Pharm Biopharm; 2024 Jun; 199():114300. PubMed ID: 38697488
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 773.